Conjugation of the TAT peptide to the surface of NPs prepared from Ch grafted poly-(N-3-carbobenzyloxy-lysine) (CPCL) was found to improve not only the cell uptake of the resulting carriers, but also the simultaneous transportation of drug (DOX) and genetic material (plasmid p53) to the nucleus of cancer cells. Here, TP53 is linked to cancer.